par Klijn, J G;Beex, Louk;Mauriac, L;van Zijl, J A;Veyret, C;Wildiers, J;Jassem, J.;Piccart-Gebhart, Martine 
;Burghouts, J;Becquart, Dominique;Seynaeve, Carine;Becquart, D;Duchateau, L
Référence Journal of the National Cancer Institute, 92, 11, page (903-911)
Publication Publié, 2000-06
;Burghouts, J;Becquart, Dominique;Seynaeve, Carine;Becquart, D;Duchateau, LRéférence Journal of the National Cancer Institute, 92, 11, page (903-911)
Publication Publié, 2000-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Klijn, J G; Beex, Louk; Mauriac, L; van Zijl, J A; Veyret, C; Wildiers, J; Jassem, J.; Piccart-Gebhart, Martine; Burghouts, J; Becquart, Dominique; Seynaeve, Carine; Becquart, D; Duchateau, L |
| Informations sur la publication: | Journal of the National Cancer Institute, 92, 11, page (903-911) |
| Statut de publication: | Publié, 2000-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Antineoplastic Agents, Hormonal -- therapeutic use | |
| Breast Neoplasms -- blood | |
| Breast Neoplasms -- drug therapy | |
| Buserelin -- therapeutic use | |
| Disease-Free Survival | |
| Drug Therapy, Combination | |
| Estradiol -- blood | |
| Estrogen Receptor Modulators -- therapeutic use | |
| Female | |
| Gonadotropin-Releasing Hormone -- blood | |
| Humans | |
| Menstrual Cycle -- drug effects | |
| Middle Aged | |
| Premenopause | |
| Prognosis | |
| Prospective Studies | |
| Risk Factors | |
| Selective Estrogen Receptor Modulators -- therapeutic use | |
| Survival Analysis | |
| Tamoxifen -- therapeutic use | |
| Time Factors | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0027-8874 |
| info:pmid/10841825 |
